- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03370354
Nursing Activity and Quality of Hospitalized Patients' Sleep (SOMACTIV)
The Impact of Night Nursing Activity on the Quality of Hospitalized Patients' Sleep
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There are 5 speciality medical units involved. Patients must respond to the define inclusion criteria. Each patient will be asked if they agree to participate and if so will be asked to consent to participate.
Every day, nurses will give a questionnaire which will be completed by the patient to know if there were troubles sleeping patterns. If so, a second questionnaire will be completed by the patient.
Other data will be recorded such as personal informations, diagnostic, medical history, consumption habits and treatments.
The inclusion phase lasts 15 days maximum.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Bridey Céline
- Phone Number: +33383154081
- Email: c.bridey@chru-nancy.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient hospitalize in medical units
- In the unit since one night
- Patient over 18 years old
- Patient agree to participate
Exclusion Criteria:
- Patient who can't answer to the questionnaire for health reasons
- Patient who need a specific surveillance
- Patient recently operated
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control group
First questionnaire (spiegel questionnaire) will allow a score on 30.
If the score is > 18, the patient will be in the control group.
|
|
troubled sleeping patterns group
First questionnaire (spiegel questionnaire) will allow a score on 30.
If the score is < 18, the patient will be in the troubled patterns group.
|
Ask patients about sleep quality and identify reasons of troubled sleeping patterns in the units.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Presence of a sleeping disorder partially or totally related, according to patient's opinion, to night nursing activity
Time Frame: At the end of participation of patient- maximum at day 15 after inclusion
|
At the end of participation of patient- maximum at day 15 after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Part of patients declaring disturbing elements related to night nursing activity
Time Frame: At day 15 after inclusion
|
A follow up sheet is completed every day by a study nurse who asks to patient if the patient sleeps well during the previous night
|
At day 15 after inclusion
|
Disturbing elements related to night nursing activity
Time Frame: Every day during 15 days
|
A follow up sheet is completed every day by a study nurse who asks to patient what was the disturbing elements according to him
|
Every day during 15 days
|
Individual and clinical disturbing elements
Time Frame: Every day during 15 days
|
A follow up sheet is completed every day by a study nurse who asks to patient what was the disturbing elements according to him
|
Every day during 15 days
|
Average length of patients' sleep in patients with troubled sleeping during hospitalization
Time Frame: Every day during 15 days
|
Estimated with the Vis Morgen self administered questionnaire
|
Every day during 15 days
|
Sleep quality measured by Spiegel score
Time Frame: Every day during 15 days
|
Score from 0 to 30
|
Every day during 15 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bridey Céline, CHRU Nancy France
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-A02076-47
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disorders, Circadian Rhythm
-
Vanda PharmaceuticalsCompletedCircadian Rhythm Sleep DisordersUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingSleep | Sleep Disturbance | Anesthesia | Sleep Disorders, Circadian Rhythm | Circadian Rhythm Sleep Disorder | Circadian Rhythm Disorder Caused by Drug | Circadian Rhythm Sleep Disorder, Jet Lag Type | Jet LagNetherlands
-
Taipei Veterans General Hospital, TaiwanNational Yang Ming UniversityRecruitingShift Work Type Circadian Rhythm Sleep DisorderTaiwan
-
University of BergenCompletedSleep | Circadian Rhythm Sleep Disorder, Delayed Sleep PhaseNorway
-
Yale UniversityCompletedCircadian Rhythm Sleep Disorder, UnspecifiedUnited States
-
University of HelsinkiAcademy of FinlandUnknownSleep Disorder Circadian Rhythm, Delayed Sleep Phase TypeFinland
-
Columbia UniversityRecruitingEating Behavior | Shift Work Type Circadian Rhythm Sleep DisorderUnited States
-
Federal University of UberlandiaCompletedShift Work Type Circadian Rhythm Sleep DisorderBrazil
-
University of Massachusetts, WorcesterNot yet recruitingFatigue | Shift Work Type Circadian Rhythm Sleep DisorderUnited States
-
Federal University of UberlandiaCompletedShift Work Type Circadian Rhythm Sleep DisorderBrazil
Clinical Trials on Observational
-
American Gastroenterological AssociationUniversity of Pennsylvania; University of California, San Diego; University of... and other collaboratorsRecruitingClostridium Difficile Infection | Gut Microbiome | Fecal Microbiota TransplantationUnited States, Canada
-
University of MinnesotaAgency for Healthcare Research and Quality (AHRQ)RecruitingTraumatic Brain Injury | Venous ThromboembolismUnited States
-
Massachusetts General HospitalRecruiting
-
Taysha Gene Therapies, Inc.Withdrawn
-
University Hospital, AntwerpUniversiteit AntwerpenUnknownType 1 Diabetes | Diastolic Dysfunction | Coronary Artery CalcificationsBelgium
-
St. Louis UniversityActive, not recruitingVertebral Artery StenosisUnited States
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
AstraZenecaRecruiting
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States